De Jure Medicines Private Limited - Company Profile

It is a professional services private limited company based in Gurgaon, Haryana, India, established in 2014.
2014 Gurgaon, Haryana, India Active
Last Updated:
Access Report
About De Jure Medicines Private Limited

De Jure Medicines Private Limited, a active private limited company, was established on 12 February 2014 in Gurgaon, Haryana, India. Engaging in taxation within the professional, scientific and technical sector, it holds CIN: U51100HR2014PTC051866. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Formerly known as De Jure Taxes Private Limited, De Jure Trade N Taxes Consortium Private Limited. It upholds a compliant status. Its leadership includes Deepak Gupta (Director), Barkha Gupta (Director). Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at House No. 56 Sector 31, Gurgaon, Haryana, 122001.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U51100HR2014PTC051866

  • Registration Number

    051866

  • Incorporation Date

    12 February 2014

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 12 Year, 2 Days
  • Last Filing with ROC 31 Mar 2025
  • Revenue Growth **** 238.69%
  • Profit Growth **** 82.08%
  • Ebitda **** 82.25%
  • Net Worth 9.82%
  • Total Assets **** 18.59%
Company report

De Jure Medicines Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into De Jure Medicines Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at De Jure Medicines Private Limited?
Current Directors
Name Designation Appointment Date Status
Deepak Gupta Director 12 Feb 2014 Current
Barkha Gupta Director 12 Feb 2014 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of De Jure Medicines.

De Jure Medicines Private Limited, for the financial year ended 2017, experienced significant growth in revenue, with a 238.69% increase. The company also saw a substantial improvement in profitability, with a 82.08% increase in profit. The company's net worth moved up by a moderate rise of 9.82%.

De Jure Medicines revenue growth over time
De Jure Medicines profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 238.69%
*******
*******
*******
*******
Revenue from Operations
*******
 238.69%
*******
*******
*******
*******
Total Assets
*******
 18.59%
*******
*******
*******
*******
Profit or Loss
*******
 82.08%
*******
*******
*******
*******
Net Worth
*******
 9.82%
*******
*******
*******
*******
EBITDA
*******
 82.25%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of De Jure Medicines?

In 2017, De Jure Medicines had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at De Jure Medicines?

Unlock and access historical data on people associated with De Jure Medicines, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of De Jure Medicines, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped De Jure Medicines's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on De Jure Medicines
Recent Activity within the Organization
  • Annual General Meeting

    The activity De Jure Medicines Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.

  • Balance Sheet

    Progress on De Jure Medicines Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was documented.

  • Director Appointment

    Deepak Gupta was appointed as a Director was appointed as a Director on 12 Feb 2014 & has been associated with this company since 12 years 2 days . was recorded as a recent event.

  • Director Appointment

    Barkha Gupta was appointed as a Director was appointed as a Director on 12 Feb 2014 & has been associated with this company since 12 years 2 days . was recorded as a recent event.

  • Company Incorporation

    The activity De Jure Medicines Private Limited was registered on 12 Feb 2014 with Roc Delhi & aged 12 years 2 days as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of De Jure Medicines Private Limited?

The CIN of De Jure Medicines Private Limited is U51100HR2014PTC051866.

Where is De Jure Medicines Private Limited headquartered?

De Jure Medicines Private Limited is headquartered at House No. 56 Sector 31, Gurgaon, Haryana, 122001.

When was De Jure Medicines Private Limited incorporated?

De Jure Medicines Private Limited was incorporated on 12 February 2014.

Who are the current directors of De Jure Medicines Private Limited?

The current directors of De Jure Medicines Private Limited are

What is the primary industry of De Jure Medicines Private Limited?

The primary industry of De Jure Medicines Private Limited is Professional, Scientific And Technical.

Is De Jure Medicines Private Limited a listed company?

De Jure Medicines Private Limited is unlisted.

What is the capital structure of De Jure Medicines Private Limited?

The authorized capital of De Jure Medicines Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

What is the compliance status of De Jure Medicines Private Limited?

The compliance status of De Jure Medicines Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available